Head-to-head · Cost-Efficiency Index
MaxLife vs Coby Health
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
MaxLife
Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing.
Visit MaxLifeCoby Health
Cost-first shoppers who want wanting real per-dose, pay-as-you-go pricing with no forced subscription, accepting that price rises with dose.
Visit Coby HealthThe verdict
MaxLife and Coby Health tie on the Cost-Efficiency Index at 58/100, so neither wins outright on the numbers. For most shoppers we'd start with MaxLife (ranked #280, a hair above #283) — Cost-first shoppers who want new patients specifically chasing the current limited-time promo, not for shoppers wanting stable published pricing. But Coby Health is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs MaxLife.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | MaxLife | Coby Health |
|---|---|---|
| Cost-Efficiency Index | 58/100 | 58/100 |
| Semaglutide / mo | $169/mo (compounded) | $159/mo (0.25 mg dose, bundle, compounded) |
| Tirzepatide / mo | $169/mo (compounded) | $239/mo (2.5 mg dose, bundle, compounded) |
| Semaglutide / yr (modeled) | $2,028 | $1,908 |
| Tirzepatide / yr (modeled) | $2,028 | $2,868 |
| Coverage | Coverage not published | 46 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #280 | #283 |
MaxLife
58/100Where the value is
- Low advertised entry price ($169) plus a free first week for new clients
- Clear phone and email contact information for direct follow-up
- Simple, straightforward homepage messaging
The tradeoffs
- Headline price is explicitly a rotating seasonal promo ('March special'), not a stable rate
- No ongoing/renewal price disclosed anywhere after the promo period
Regulatory note: the FDA issued a warning letter to MaxLife Technologies Inc. dba Maxlife in February 2026. We still list and link to MaxLife; you should know the letter is on the public record before you decide.
Coby Health
58/100Where the value is
- Genuine per-dose pricing transparency — every dose tier has its own published monthly price rather than one vague 'starting at' figure
- No subscription requirement: 'cancel your monthly subscription anytime for a one-month supply'
- Multi-month and titration-specific bundles are priced and disclosed up front, not hidden behind checkout
The tradeoffs
- The advertised low headline prices ('as low as $99/mo' semaglutide, '$179/mo' tirzepatide) apply only to the LOWEST starting dose on a 6-month bundle — real pay-as-you-go pricing at a typical mid-range dose is far higher
- Coby Health is explicitly a marketplace connecting patients to independent third-party providers — no medical director, prescriber, or compounding pharmacy is named anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.